表紙
市場調查報告書

靜脈通路裝置的全球市場 - 至2022年的預測:各類型 、用途 (投藥,液體、營養給藥),終端用戶

Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022

出版商 MarketsandMarkets 商品編碼 534646
出版日期 內容資訊 英文 141 Pages
訂單完成後即時交付
價格
Back to Top
靜脈通路裝置的全球市場 - 至2022年的預測:各類型 、用途 (投藥,液體、營養給藥),終端用戶 Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - Global Forecasts to 2022
出版日期: 2017年07月21日內容資訊: 英文 141 Pages
簡介

靜脈通路裝置市場預計從2017年的38億7,000萬美元,以年複合成長率7.1%擴大,到2022年成為54億5,000萬美元。文明病的罹患率上升,化療數量的增加,兒童患者的靜脈通路裝置的使用增加等帶動市場成長。

本報告提供全球靜脈通路裝置市場相關調查,市場概要和各類型,各用途,各終端用戶,各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 簡介

  • 本調查的目的
  • 市場定義
  • 市場範圍
  • 考慮的貨幣
  • 限制
  • 相關利益者

第2章 調查方法

第3章 摘要整理

第4章 高級見解

第5章 市場概要

  • 簡介
  • 市場發展
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題

第6章 各類型市場

  • 簡介
  • 中心靜脈通路裝置
  • 末梢靜脈通路裝置
  • 配件

第7章 各用途市場

  • 簡介
  • 投藥
  • 液體、營養給藥
  • 輸血
  • 診斷、檢驗

第8章 各終端用戶市場

  • 簡介
  • 醫院
  • 診療所,門診病人照護中心
  • 其他

第9章 各地區市場

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 市場排行榜
  • 競爭領導製圖
  • 競爭基準

第11章 企業簡介

  • BECTON, DICKINSON AND COMPANY
  • C.R.BARD, INC.
  • TELEFLEX INCORPORATED
  • SMITHS MEDICAL, INC.
  • B BRAUN MELSUNGEN AG
  • ANGIODYNAMICS (NAVILYST MEDICAL, INC)
  • TERUMO CORPORATION
  • NIPRO MEDICAL CORPORATION
  • EDWARDS LIFESCIENCES CORPORATION
  • AMECO MEDICAL
  • ROMSONS SCIENTIFIC & SURGICAL PVT. LTD.
  • PRODIMED

第12章 附錄

目錄
Product Code: MD 5434

"Vascular access devices market is projected to grow at a CAGR of 7.1%"

The global vascular access device market is estimated to grow at a CAGR of 7.1% to reach USD 5.45 billion by 2022 from USD 3.87 billion in 2017. The key factors driving the growth of this market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients. However, high costs involved in the placement and maintenance of vascular access devices and product recalls and failures may hinder the growth of the market to a certain extent during the forecast period.

"The central vascular access device segment to dominate the global vascular access devices market during the forecast period"

By type, the vascular access devices market is segmented into central vascular access devices, peripheral vascular access devices, and accessories. The central vascular access devices segment is not only expected to account for the largest share of the vascular access devices market in 2017, but also grow at the highest CAGR during the forecast period. The growth of this segment is attributed to the wide usage of central vascular access devices in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.

"The drug administration segment is projected to grow at the highest CAGR during the forecast period"

On the basis of application, the vascular access devices market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. The drug administration segment is expected to grow at the highest CAGR in 2017. This positive growth rate can primarily be attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.

"Asia-Pacific to witness the highest growth during the forecast period (2017-2022)"

North America held the largest share of the global vascular access devices market in 2016, while Asia-Pacific is expected to witness the highest growth during 2017 to 2022. Rapid growth in aging population and CKD, CKS, & diabetes prevalence, along with healthcare reforms and investments in Asia-Pacific countries, are key factors driving the market for this geographic segment.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-55%, Tier 2-25% and Tier 3-20%
  • By Designation - C-level-43%, Director Level-32%, Others-25%
  • By Region - North America-38%, Europe-23%, Asia-Pacific-29%, RoW-10%

Some of the major players include Becton Dickinson and Company (U.S.), Smiths Medical, Inc. (U.K.), and C. R. Bard, Inc. (U.S.). Other players include Teleflex Incorporated (U.S.) B. Braun Melsungen Ag (Germany), AngioDynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodimed (France).

Research Coverage:

The report analyzes the vascular access device market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application, end user and region. The report also includes an in-depth regulatory analysis for various regions across the globe and the competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global vascular access devices market. The report analyzes the vascular access devices market by type, application, end user, and region.
  • Service Enhancement/Innovation: Detailed insights on upcoming trends and new service launches in the global vascular access devices market.
  • Market Development: Comprehensive information about the lucrative emerging markets by type, application, end user, and region.
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the vascular access devices market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products and services of leading players in the global vascular access devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key insights from primary sources
    • 2.2.3. KEY INDUSTRY INSIGHTS
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET FORECAST METHODOLOGY
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS OF THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. VASCULAR ACCESS DEVICES: MARKET OVERVIEW (2017-2022)
  • 4.2. VASCULAR ACCESS DEVICES MARKET, BY TYPE (2017)
  • 4.3. VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2017 VS. 2022
  • 4.4. VASCULAR ACCESS DEVICES MARKET, BY END USER, 2017 VS. 2022
  • 4.5. GEOGRAPHIC SNAPSHOT OF THE VASCULAR ACCESS DEVICES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing prevalence of lifestyle diseases
      • 5.2.1.2. Increasing number of chemotherapy procedures
      • 5.2.1.3. Increasing use of vascular access devices in pediatric patients
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High costs involved in the placement and maintenance of vascular access devices
      • 5.2.2.2. Product recalls and failures
    • 5.2.3. OPPORTUNITY
      • 5.2.3.1. Technological advancements
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Shortage of skilled professionals
      • 5.2.4.2. Risks associated with vascular access devices

6. GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. CENTRAL VASCULAR ACCESS DEVICES
    • 6.2.1. PERIPHERALLY INSERTED CENTRAL CATHETERS
    • 6.2.2. TUNNELED CATHETERS
    • 6.2.3. NON-TUNNELED CATHETERS
    • 6.2.4. IMPLANTED PORTS
  • 6.3. PERIPHERAL VASCULAR ACCESS DEVICES
    • 6.3.1. PERIPHERAL SHORT DEVICES
    • 6.3.2. PERIPHERAL MIDLINE DEVICES
    • 6.3.3. BUTTERFLY/WINGED STEEL NEEDLES
  • 6.4. ACCESSORIES

7. GLOBAL VASCULAR ACCESS DEVICES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. DRUG ADMINISTRATION
  • 7.3. FLUID AND NUTRITION ADMINISTRATION
  • 7.4. BLOOD TRANSFUSION
  • 7.5. DIAGNOSTICS AND TESTING

8. GLOBAL VASCULAR ACCESS DEVICES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS
  • 8.3. CLINICS AND AMBULATORY CARE CENTERS
  • 8.4. OTHER END USERS

9. VASCULAR ACCESS DEVICES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Rising prevalence of CVD
      • 9.2.1.2. Increasing number of cancer cases
      • 9.2.1.3. Increase in research and clinical trials for vascular access devices
      • 9.2.1.4. Conferences, meetings, symposia, and workshops
    • 9.2.2. CANADA
      • 9.2.2.1. Increasing number of cardiac arrest cases
      • 9.2.2.2. Increase in cancer incidence
      • 9.2.2.3. Increasing number of minimally invasive procedures
  • 9.3. EUROPE
    • 9.3.1. INCREASING FOCUS OF MARKET PLAYERS ON EUROPE
    • 9.3.2. NEW RULES AND REGULATIONS FOR MEDICAL DEVICES
    • 9.3.3. RISING GERIATRIC POPULATION
    • 9.3.4. E-3
      • 9.3.4.1. Rising prevalence of CVD in U.K. and Germany
      • 9.3.4.2. Growing prevalence of cancer in EU-3
      • 9.3.4.3. Increasing prevalence of lifestyle diseases in the U.K.
      • 9.3.4.4. Favorable government support, growth in aging population in France
      • 9.3.4.5. Prevalence of ESRD and need for dialysis treatment
    • 9.3.5. ROE
      • 9.3.5.1. Improving healthcare structure in Russia
      • 9.3.5.2. Turkey: Growth in the healthcare sector, rising medical tourism
  • 9.4. ASIA-PACIFIC
    • 9.4.1. INCREASING CHRONIC KIDNEY DISEASE PREVALENCE IN JAPAN
    • 9.4.2. JAPAN & CHINA: RAPID GROWTH IN GERIATRIC POPULATION
    • 9.4.3. HEALTHCARE REFORMS, GOVERNMENT INITIATIVES, AND INVESTMENTS IN CHINA AND JAPAN
  • 9.5. REST OF THE WORLD
    • 9.5.1. PREVALENCE OF CKD AND GOVERNMENT INITIATIVES IN THE ROW
    • 9.5.2. MIDDLE EAST: INCREASING GERIATRIC POPULATION, RISE IN AGE-RELATED DISORDERS
    • 9.5.3. GROWING MEDICAL TOURISM IN THE ROW
    • 9.5.4. HIGH PREVALENCE OF OBESITY IN LATIN AMERICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. MARKET RANKING (AS OF 2016)
    • 10.3.1. VENDOR INCLUSION CRITERIA
  • 10.4. COMPETITIVE LEADERSHIP MAPPING (2017)
    • 10.4.1. VISIONARY LEADERS
    • 10.4.2. INNOVATORS
    • 10.4.3. DYNAMIC DIFFERENTIATORS
    • 10.4.4. EMERGING COMPANIES
  • 10.5. COMPETITIVE BENCHMARKING
    • 10.5.1. STRENGTH OF PRODUCT PORTFOLIO
    • 10.5.2. BUSINESS STRATEGY EXCELLENCE

Top 25 companies analyzed for this studies are - Smiths Medical (U.S.), Terumo Medical Corporation (Japan), Becton Dickinson and Company (U.S.), Teleflex Incorporated (U.S.), C.R.Bard, Inc. (U.S.), B Braun Melsungen AG. (Germany), NIPRO Medical Corporation (Japan), Vygon Ltd. (U.K.), Ameco Medical (Egypt), Romson Scientific (India), PRODIMED (France), Edward Lifescience Corporation LLC (U.S.), AngioDynamics (U.S.), Biosensors International Group, Ltd (Singapore), Centurion Medical Products (U.S.), Fresenius Medical Care Asia Pacific Limited (Hong Kong), Access Scientific, LLC (U.S.), 3M. (U.S.), ZOLL Medical Corporation (U.S.), Medtronic Plc (Ireland), Baxter International Inc. (U.S.), Merit Medical System, Inc. (U.S.), Hospira (U.S.), Bionic Medizintechnik GmbH (Germany), Medical Components, Inc. (U.S)

11. COMPANY PROFILES (Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments)*

  • 11.1. BECTON, DICKINSON AND COMPANY
  • 11.2. C.R.BARD, INC.
  • 11.3. TELEFLEX INCORPORATED
  • 11.4. SMITHS MEDICAL, INC.
  • 11.5. B BRAUN MELSUNGEN AG
  • 11.6. ANGIODYNAMICS (NAVILYST MEDICAL, INC)
  • 11.7. TERUMO CORPORATION
  • 11.8. NIPRO MEDICAL CORPORATION
  • 11.9. EDWARDS LIFESCIENCES CORPORATION
  • 11.10. AMECO MEDICAL
  • 11.11. ROMSONS SCIENTIFIC & SURGICAL PVT. LTD.
  • 11.12. PRODIMED

*Details on MarketsandMarkets view, Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 2: GLOBAL CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: TUNNELED CATHETERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NON-TUNNELED CATHETERS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: IMPLANTED PORTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 9: PERIPHERAL VASCULAR ACCESS DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: PERIPHERAL SHORT DEVICES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: PERIPHERAL MIDLINE DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: BUTTERFLY/WINGED STEEL NEEDLES MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: VASCULAR ACCESS DEVICES MARKET FOR ACCESSORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 15: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: VASCULAR ACCESS DEVICES MARKET FOR FLUID AND NUTRITION ADMINISTRATION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS AND TESTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 20: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: VASCULAR ACCESS DEVICES MARKET SIZE FOR CLINICS AND AMBULATORY CARE CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 30: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED
  • TABLE 31: INDICATIVE LIST OF RECENT EVENTS IN THE U.S.
  • TABLE 32: U.S.: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 33: U.S.: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: U.S.: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 35: U.S.: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 36: U.S.: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 37: CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 39: CANADA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 40: CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 41: CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 42: GERIATRIC POPULATION IN EUROPEAN COUNTRIES (AS A PERCENTAGE OF THE TOTAL)
  • TABLE 43: EUROPE: VASCULAR ACCESS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: E-3: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: E-3: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: E-3: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: E-3: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 53: E-3: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 54: ROE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: ROE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: ROE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: ROE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 58: ROE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA -PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 64: PERCENTAGE OF OBESE POPULATION IN LATIN AMERICAN COUNTRIES
  • TABLE 65: ROW: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: ROW: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: ROW: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: ROW: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: ROW: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY: GLOBAL VASCULAR ACCESS DEVICES
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 4: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: RESEARCH DESIGN: GLOBAL VASCULAR ACCESS DEVICES
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (2017)
  • FIGURE 10: GLOBAL VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: GLOBAL VASCULAR ACCESS DEVICES MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 12: GEOGRAPHICAL SNAPSHOT OF THE VASCULAR ACCESS DEVICES MARKET
  • FIGURE 13: RISING PREVALENCE OF LIFESTYLE DISEASES IS THE MAJOR FACTOR DRIVING THE GROWTH OF THE VASCULAR ACCESS DEVICES MARKET
  • FIGURE 14: CENTRAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 15: DRUG ADMINISTRATION SEGMENT WILL CONTINUE TO DOMINATE THE VASCULAR ACCESS DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: HOSPITALS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 17: APAC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 18: GLOBAL VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: CENTRAL VASCULAR ACCESS DEVICES TO COMMAND THE LARGEST SHARE OF THE GLOBAL VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 20: PERIPHERALLY INSERTED CENTRAL CATHETERS TO COMMAND THE LARGEST SHARE OF THE GLOBAL CENTRAL VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 21: PERIPHERAL SHORT DEVICES TO COMMAND THE LARGEST SHARE OF THE GLOBAL PERIPHERAL VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 22: DRUG ADMINISTRATION TO FORM THE LARGEST END-USER SEGMENT IN THE VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 23: HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN THE VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 24: NORTH AMERICA TO DOMINATE THE VASCULAR ACCESS DEVICES MARKET IN 2017
  • FIGURE 25: NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
  • FIGURE 26: EUROPE: VASCULAR ACCESS DEVICES SNAPSHOT
  • FIGURE 27: CANCER INCIDENCE IN EU-3
  • FIGURE 28: ASIA-PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
  • FIGURE 29: ROW: VASCULAR ACCESS DEVICES MARKET SNAPSHOT
  • FIGURE 30: GLOBAL VASCULAR ACCESS DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2016)
  • FIGURE 31: COMPETITIVE LEADERSHIP MAPPING: VASCULAR ACCESS DEVICE MARKET
  • FIGURE 32: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 33: C.R.BARD INC. COMPANY SNAPSHOT (2016)
  • FIGURE 34: TELEFLEX INCORPORATED. COMPANY SNAPSHOT (2016)
  • FIGURE 35: SMITHS MEDICAL INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 36: B BRAUN MELSUNGEN AG COMPANY SNAPSHOT (2016)
  • FIGURE 37: ANGIODYNAMICS COMPANY SNAPSHOT (2016)
  • FIGURE 38: TERUMO CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 39: NIPRO MEDICAL CORPORATION COMPANY SNAPSHOT (2016)
  • FIGURE 40: EDWARDS LIFESCIENCES CORPORATION COMPANY SNAPSHOT (2016)
Back to Top